The Danish Rheumatism Association   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Gentofte Denmark (1936)

Organization Overview

First Clinical Trial
2005
NCT00833157
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Danish Rheumatism Association

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Fasciitis (Phase 4)

Fasciitis, Plantar (Phase 4)

Osteoarthritis (Phase 1)

Osteoarthritis, Knee (Phase 1)

Psoriasis (Phase 4)

Shoulder Impingement Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 11